Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome

Metabolomics

Volumn 10, Issue 3, 2014, Pages 414-424

  Laborde, Carlos M ^a   Mourino Alvarez, Laura ^a   Posada Ayala, María ^b   Alvarez Llamas, Gloria ^b   Serranillos Reus, Manuel Gómez ^c   Moreu, José ^c   Vivanco, Fernando ^b,d   Padial, Luis R ^c   Barderas, María G ^a  

^a HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^b 28400 Madrid   (Spain)

^c HOSPITAL VIRGEN DE LA SALUD   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Acute coronary syndrome; Biomarker; Metabolite; Metabolomics

Indexed keywords

2 HYDROXYBUTYRIC ACID; 2, 4, 5 TRIHYDROXYVALERIC ACID; 3 HYDROXYBUTYRIC ACID; 4 HYDROXYPHENYLACETIC ACID; 5 HYDROXYTRYPTOPHAN; ACENAPHTHYLENE; AMINO ACID; BIOLOGICAL MARKER; CYSTATHIONINE; GLUCONIC ACID; GLYCERIC ACID; HEPTADECANOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALIC ACID; N ACETYLGLUCOSAMINE; OXALIC ACID; PALMITIC ACID; SALICYLIC ACID; SORBITOL; TERBUTALINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; EARLY DIAGNOSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OXIDATIVE STRESS; PATIENT SELECTION; PROTEIN ANALYSIS; RISK FACTOR; SMOKING; TRANSESTERIFICATION; VALIDATION PROCESS;

EID: 84898546574     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-013-0595-9     Document Type: Article

References (38)

1. Arora, S., & Menchine, M. (2012). The role of point-of-care β-hydroxybutyrate testing in the diagnosis of diabetic ketoacidosis: A review. Hospital Practice (1995), 40(2), 73-78.
2. Baldus, S., Heeschen, C., Meinertz, T., Zeiher, A. M., Eiserich, J. P., Munzel, T., et al. (2003). Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation, 108, 1440-1445.
3. Bassand, J. P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., et al. (2007). Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. European Heart Journal, 28, 1598-1660.
4. Boernsen, K. O., Gatzek, S., & Imbert, G. (2005). Controlled protein precipitation in combination with chip-based nanospray infusion mass spectrometry. An approach for metabolomics profiling of plasma. Analytical Chemistry, 77(22), 7255-7264.
5. Brennan, M. L., Penn, M. S., van Lente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., et al. (2003). Prognostic value of myeloperoxidase in patients with chest pain. New England Journal of Medicine, 349, 1595-1604.
6. Chen, J., Zhao, X., Fritsche, J., Yin, P., Schmitt-Kopplin, P., Wang, W., et al. (2008). Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Analytical Chemistry, 80(4), 1280-1289.
7. Chew, D., Allan, R., Aroney, C., & Sheerin, N. (2005). National data elements for the clinical management of acute coronary syndromes. Medical Journal of Australia, 182(9 Suppl), S1-S16.
8. Fiehn, O., Kopka, J., Dörmann, P., Altmann, T., Trethewey, R. N., & Willmitzer, L. (2000). Metabolite profiling for plant functional genomics. Nature Biotechnology, 18(11), 1157-1161.
9. García-Pinilla, J. M., Gálvez, J., Cabrera-Bueno, F., Jiménez-Navarro, M., Gómez-Doblas, J. J., Galisteo, M., et al. (2008). Baseline glutathione peroxidase activity affects prognosis after acute coronary síndromes. Texas Heart Institute Journal, 35(3), 262-267.
10. Hackam, D. G., & Anand, S. S. (2003). Emerging risk factors for atherosclerotic vascular disease: A critical review of the evidence. Journal of the American Medical Association, 290(7), 932-940.
11. Han, L. D., Xia, J. F., Liang, Q. L., Wang, Y., Wang, Y. M., Hu, P., et al. (2011). Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy. Analytica Chimica Acta, 689(1), 85-91.
12. Hansson, G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine, 352, 1685-1695.
13. Heeschen, C., Dimmeler, S., Hamm, C. W., van den Brand, M. J., Boersma, E., Zeiher, A. M., et al. (2003). Soluble CD40 ligand in acute coronary syndromes. New England Journal of Medicine, 348, 1104-1111.
14. Heeschen, C., Hamm, C. W., Bruemmer, J., & Simoons, M. L. (2000). Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina Refractory to standard treatment trial. Journal of the American College of Cardiology, 35, 1535-1542.
15. James, S. K., Lindahl, B., Siegbahn, A., Stridsberg, M., Venge, P., Armstrong, P., et al. (2003). N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies to open occluded arteries (GUSTO)-IV substudy. Circulation, 108, 275-281.
16. Jiye, A., Gullberg, J., Johansson, A. I., Jonsson, P., Antti, H., Marklund, S. L., et al. (2005). Extraction and GC/MS analysis of the human blood plasma metabolome. Analytical Chemistry, 77, 8086-8094.
17. Kemsley, E. K., Le Gall, G., Dainty, J. R., Watson, A. D., Harvey, L. J., et al. (2007). Multivariate techniques and their application in nutrition: A metabolomics case study. British Journal of Nutrition, 98(1), 1-14.
18. Kind, T., Tolstikov, V., Fiehn, O., & Weiss, R. H. (2007). A comprehensive urinary metabolomic approach for identifying kidney cancer. Analytical Biochemistry, 363(2), 185-195.
19. Lepage, G., & Roy, C. C. (1986). Direct transesterification of all classes of lipids in a one-step reaction. Journal of Lipid Research, 27, 114-120.
20. Lewis, G. D., Wei, R., Liu, E., et al. (2008). Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. Journal of Clinical Investigation, 118(10), 3503-3512.
21. Libby, P., Ridker, P. M., & Maseri, A. (2002). Inflammation and atherosclerosis. Circulation, 105(9), 1135-1143.
22. Mayr, M., Yusuf, S., Weir, G., et al. (2008). Combined metabolomic and proteomic analysis of human atrial fibrillation. Journal of the American College of Cardiology, 51(5), 585-594.
23. Meyer, M. R., Weber, A. A., & Maurer, H. H. (2011). A validated GC-MS procedure for fast, simple, and cost-effective quantification of glycols and GHB in human plasma and their identification in urine and plasma developed for emergency toxicology. Analytical and Bioanalytical Chemistry, 400(2), 411-414.
24. Oliver, S. G., Winson, M. K., Kell, D. B., & Baganz, F. (1998). Systematic functional analysis of the yeast genome. Trends in Biotechnology, 16(9), 373-378.
25. Ooi, E. M., Chan, D. T., Watts, G. F., Chan, D. C., Ng, T. W., Dogra, G. K., et al. (2011). Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease. Journal of Lipid Research, 52(4), 794-800.
26. Paige, L. A., Mitchell, M. W., Krishnan, K. R., Kaddurah-Daouk, R., & Steffens, D. C. (2007). A preliminary metabolomic analysis of older adults with and without depression. International Journal of Geriatric Psychiatry, 22(5), 418-423.
27. Pasikanti, K. K., Ho, P. C., & Chan, E. C. (2008). Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. Journal of Chromatography B, 871(2), 202-211.
28. Roger, V. L., et al. (2011). Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation, 123(4), e18-e209.
29. Salek, R. M., Maguire, M. L., Bentley, E., Rubtsov, D. V., Hough, T., Cheeseman, M., et al. (2007). A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiological Genomics, 29(2), 99-108.
30. Shen, Q., Rigor, R. R., Pivetti, C. D., Wu, M. H., & Yuan, S. Y. (2010). Myosin light chain kinase in microvascular endothelial barrier function. Cardiovascular Research, 87(2), 272-280.
31. Tweeddale, H., Notley-Mcrobb, L., & Ferenci, T. (1998). Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool ('metabolome') analysis. Journal of Bacteriology, 180(19), 5109-5116.
32. Vallejo, M., García, A., Tuñón, J., García-Martínez, D., Angulo, S., Martin-Ventura, J. L., et al. (2009). Plasma fingerprinting with GC-MS in acute coronary syndrome. Analytical and Bioanalytical Chemistry, 394(6), 1517-1524.
33. van der Greef, J., Martin, S., Juhasz, P., Adourian, A., Plasterer, T., Verheij, E. R., et al. (2007). The art and practice of systems biology in medicine: Mapping patterns of relationships. Journal of Proteome Research, 6(4), 1540-1559.
34. van Olffen, R. W., de Bruin, A. M., Vos, M., Staniszewska, A. D., Hamann, J., van Lier, R. A., et al. (2010). CD70-driven chronic immune activation is protective against aterosclerosis. Journal of Innate Immunity, 2(4), 344-352.
35. Varo, N., de Lemos, J. A., Libby, P., Morrow, D. A., Murphy, S. A., Nuzzo, R., et al. (2003). Soluble CD40L: Risk prediction after acute coronary syndromes. Circulation, 108, 1049-1052.
36. Waterman, C. L., Kian-Kai, C., & Griffin, J. L. (2010). Metabolomic strategies to study lipotoxicity in cardiovascular disease. Biochimica et Biophysica Acta, 1801(3), 230-234.
37. Wilson, P. W. (2008). Progressing from risk factors to omics. Circulation Cardiovascular Genetics, 1(2), 141-146.
38. Zeng, M., Liang, Y., Li, H., Wang, M., Wang, B., Chen, X., et al. (2010). Plasma metabolic fingerprinting of childhood obesity by GC/MS in conjunction with multivariate statistical analysis. Journal of Pharmaceutical and Biomedical Analysis, 52(2), 265-272.